The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
Last week, the FDA said Lilly had sufficiently met demand for its tirzepatide products, Mounjaro and Zepbound, so they are no ...
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback